-95%

est. 2Y upside i

HealthcareSeed

Telemedicine platform for chronic conditions like obesity

Rank

#4021

Sector

Telehealth

Est. Liquidity

~6Y

Data Quality

Data: Low

This equity opportunity carries extremely high risk due to the very limited reported funding and intense competitive landscape, making substantial upside highly speculative and contingent on an immediate, significant capital infusion and flawless execution in a challenging, regulated market.

Last updated: February 16, 2026

Bull (15%)+300%

Measured Health successfully secures substantial follow-on funding, executes flawlessly to differentiate its personalized GLP-1 telehealth platform, and captures significant market share despite intense competition.

Base (25%)+25%

Measured Health continues to operate and generate revenue, but growth is modest due to limited capital and strong competitive pressures, leading to a small valuation increase or a flat outcome.

Bear (60%)-95%

Measured Health struggles to raise additional capital, fails to effectively compete against well-funded incumbents, or faces insurmountable regulatory hurdles, leading to a significant loss of value or company failure.

Est. time to liquidity~6.0 years

Community

Valuation Sentiment

Our model estimates -95% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.